ELI LILLY & Co — Director's Dealing 2014

Feb 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-02-01

Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-01	Common Stock	M	15674	—	Acquired	105099	Direct
2014-02-01	Common Stock	F	7363	$54.01	Disposed	97736	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-01	Restricted Stock Unit	$	M	15674	Disposed	2014-02-01	Common Stock (15674.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4545	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.